Overview
Scott Haake is an Oncologist practicing medicine in Nashville, Tennessee.
Dr. Haake is highly rated in 1 condition, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), WT1-Related Wilms Tumor Syndromes, Clear Cell Sarcoma, and Chromophobe Renal Cell Carcinoma.
He is actively involved in clinical research, co-authoring 24 peer reviewed articles and participating in 1 clinical trial. Dr. Haake is currently accepting new patients.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- HMO
- PPO
Locations
2220 Pierce Ave, Nashville, TN 37232
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Tennessee Oncology, PLLC-#412 25th Ave
Ian Flinn is an Oncologist practicing medicine in Nashville, Tennessee. Dr. Flinn is highly rated in 39 conditions, according to our data. His clinical expertise encompasses Small Lymphocytic Lymphoma (SLL), Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Non-Hodgkin Lymphoma, and Bone Marrow Aspiration. Dr. Flinn is board certified in The American Board Of Internal Medicine - Hematology. Dr. Flinn is currently accepting new patients.
Tennessee Oncology, PLLC-#412 25th Ave
Jesus Berdeja is an Oncologist practicing medicine in Nashville, Tennessee. Dr. Berdeja is highly rated in 31 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Acute Myeloid Leukemia (AML), and Bone Marrow Aspiration. Dr. Berdeja is board certified in The American Board Of Internal Medicine - Hematology. Dr. Berdeja is currently accepting new patients.
Scri Oncology Partners
David Spigel is an Oncologist practicing medicine in Nashville, Tennessee. Dr. Spigel is highly rated in 29 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and Pleuropulmonary Blastoma. Dr. Spigel is board certified in The American Board Of Internal Medicine - Medical Oncology. Dr. Spigel is currently accepting new patients.
Frequently Asked Questions about Dr. Scott M. Haake
How do I make an appointment with Dr. Scott M. Haake?
You can book an appointment with Dr. Scott M. Haake by calling their office at 615-936-8422. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Scott M. Haake a top-rated expert for Renal Cell Carcinoma (RCC)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Scott M. Haake is classified as an Advanced expert for Renal Cell Carcinoma (RCC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Scott M. Haake specialize in?
While Dr. Scott M. Haake is a Oncology, they have specific expertise in Renal Cell Carcinoma (RCC), WT1-Related Wilms Tumor Syndromes, and Clear Cell Sarcoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Scott M. Haake participate in research or clinical trials?
Yes. Dr. Scott M. Haake has published 24 articles and abstracts on conditions like Renal Cell Carcinoma (RCC). You can view a list of Dr. Scott M. Haake's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Scott M. Haake accept my insurance?
Dr. Scott M. Haake accepts most major insurance plans, including Alliant Health and Blue Cross Blue Shield. We recommend calling the office directly at 615-936-8422 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Renal Cell Carcinoma (RCC)Dr. Haake isAdvanced. Learn about Renal Cell Carcinoma (RCC).
- Experienced
- Chromophobe Renal Cell CarcinomaDr. Haake isExperienced. Learn about Chromophobe Renal Cell Carcinoma.
- Clear Cell SarcomaDr. Haake isExperienced. Learn about Clear Cell Sarcoma.
- Familial Wilms Tumor 2Dr. Haake isExperienced. Learn about Familial Wilms Tumor 2.
- Wilms TumorDr. Haake isExperienced. Learn about Wilms Tumor.
- WT1-Related Wilms Tumor SyndromesDr. Haake isExperienced. Learn about WT1-Related Wilms Tumor Syndromes.